由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Biology版 - Helicos Seeks Approval to Sell Assets 真是大浪淘沙
相关主题
第三代测序技术简介More Life-Science Jobs Despite Recession
Top 10 Most-Read Articles for 2010 on GenomeWeb Daily NewsObama Says Research Investments Needed
Helicos BioSciences申请破产保护咱们又多出3倍的 SNPs 了
第三代测序公司Helicos宣布破产有没有纯生物背景创业成功的例子
Roche买了Genia了,一个和Oxford Nano竞争的startupObama's Budget Proposal Includes NIH Funding Bump, Supports Long-term Plan at NHGRI
讨论:Next-Gen Sequencing Is A Numbers GameBig news: Thermo Fisher Buying Life Technologies for $13.6B
Data Scientist, Biochemistry/Biophysics高通量NGS测序是不是一个好的职业方向
information on nucleotides around restriction enzymeTed Stanley Pledges $650M to Broad's Stanley Center for Psychiatric Genome Research
相关话题的讨论汇总
话题: helicos话题: jones话题: assets话题: company话题: its
进入Biology版参与讨论
1 (共1页)
s******9
发帖数: 283
1
Single-molecule技术,怎么才能robust...
Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company
March 11, 2013
NEW YORK (GenomeWeb News) – Helicos BioSciences, currently in Chapter 11
bankruptcy protection, is seeking approval from bankruptcy court to sell its
assets to an employee who plans to form a new company using Helicos'
technology, the company said in a court filing last week.
The US Bankruptcy Court for the District of Massachusetts Eastern Division
will hold a hearing on Helicos' motion for approval of the proposed deal on
Thursday.
According to the motion, Helicos employee Dan Jones wants to buy the company
's assets. He also is seeking a non-exclusive license from Helicos covering
its technology in order to build a new entity that will perform sequencing
services on a contract basis in support of Helicos' existing customer base "
and potentially improving [Helicos'] existing technology."
Jones, Helicos said, is a scientist and has never served as a director or
officer of the company.
Among the assets that Jones would acquire are Helicos' equipment, including
its HeliScope single-molecule sequencers, data analysis systems, and
engineering computers; all inventory and supplies including reagents; and
all customer records and engineering documentation.
Helicos would also grant Jones a sublicense to its IP, originally licensed
from Arizona Science and Technology Enterprise, related to nucleic acid
sequencing-by-synthesis "utilizing detection of optical-labeled nucleotides
… and performed without reliance on detection of optically labeled
nucleotides," the firm said.
Under the terms of the deal, Jones would make an initial payment to Helicos
of $75,000. The company would also issue a promissory note in the principal
amount of $500,000 with a non-default interest rate of 3 percent "secured by
a second priority security interest in all assets acquired" from Helicos by
Jones.
Jones would have to carry out Helicos' unfulfilled customer orders and
deferred customer obligations "whether [he] will realize any revenue
therefrom (and in most cases, [Jones] will not)," according to the filing.
Jones would have the rights to use the Helicos and Helicos BioSciences name
in connection with the new business.
Helicos said that two of the three claimants on its bankruptcy filing
asserting liens against Helicos' assets have agreed to the deal, while the
third "has expressed no objection to the [company's] request for expedited
determination or relief requested herein."
Helicos must vacate its current location in Cambridge, Mass., by the end of
the month, and "[t]he purpose of the transaction is to relieve the company
of assets and obligations that will constitute a net drain on the company's
cash flow if retained after March 31, 2013," the firm said in its court
document.
Helicos filed for Chapter 11 protection, which allows a company to
reorganize its operations, in November after its board determined "that
continued operation of the company outside of bankruptcy protection is not
possible due to its lack of cash resources and no available funding
operations."
In its bankruptcy filing, the company listed total assets of $3.5 million
and total debts of $15.5 million as of Sept. 30, 2012.
s********n
发帖数: 2939
2
这个Scientist买了以后可以继续对现有客户提供服务?
s********n
发帖数: 2939
3
这个Scientist买了以后可以继续对现有客户提供服务?
s******9
发帖数: 283
4
产品中断了,大家都不需要服务了吧。million dollar的仪器难道就废弃了?
能scan single-molecule signals的平台,迟早会用处大,不过要robust的测序,不容
易。这个scienist很明智啊。
1 (共1页)
进入Biology版参与讨论
相关主题
Ted Stanley Pledges $650M to Broad's Stanley Center for Psychiatric Genome ResearchRoche买了Genia了,一个和Oxford Nano竞争的startup
Broad目前握有专利,但CRISPR的专利之争似乎有利于UC?讨论:Next-Gen Sequencing Is A Numbers Game
给个原创的,临床相关的aging生物信息研究的例子Data Scientist, Biochemistry/Biophysics
国际媒体对韩春雨NgAgo论文被撤的反应information on nucleotides around restriction enzyme
第三代测序技术简介More Life-Science Jobs Despite Recession
Top 10 Most-Read Articles for 2010 on GenomeWeb Daily NewsObama Says Research Investments Needed
Helicos BioSciences申请破产保护咱们又多出3倍的 SNPs 了
第三代测序公司Helicos宣布破产有没有纯生物背景创业成功的例子
相关话题的讨论汇总
话题: helicos话题: jones话题: assets话题: company话题: its